175 related articles for article (PubMed ID: 10549447)
1. Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing vaginal ring in Chilean nursing women.
Massai R; Miranda P; Valdés P; Lavín P; Zepeda A; Casado ME; Silva MA; Fetis G; Bravo C; Chandía O; Peralta O; Croxatto HB; Díaz S
Contraception; 1999 Jul; 60(1):9-14. PubMed ID: 10549447
[TBL] [Abstract][Full Text] [Related]
2. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
[TBL] [Abstract][Full Text] [Related]
3. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
4. Contraception with progestogens and progesterone during lactation.
Shaaban MM
J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
[TBL] [Abstract][Full Text] [Related]
5. Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trial.
Massai R; Quinteros E; Reyes MV; Caviedes R; Zepeda A; Montero JC; Croxatto HB
Contraception; 2005 Nov; 72(5):352-7. PubMed ID: 16246661
[TBL] [Abstract][Full Text] [Related]
6. Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.
Roy M; Hazra A; Merkatz R; Plagianos M; Alami M; Gaur LN; Aruldas K; Sussman H; Variano B; Sitruk-Ware R;
Contraception; 2020 Sep; 102(3):159-167. PubMed ID: 32360666
[TBL] [Abstract][Full Text] [Related]
7. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
Souza JP; Andrade AT; Pizarro E
Bol Cent Biol Reprod; 1991; 10(1):26-32. PubMed ID: 12318141
[TBL] [Abstract][Full Text] [Related]
8. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.
Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT
Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061
[TBL] [Abstract][Full Text] [Related]
9. Use of a single implant of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for postpartum nursing women.
Coutinho EM; Athayde C; Dantas C; Hirsch C; Barbosa I
Contraception; 1999 Feb; 59(2):115-22. PubMed ID: 10361626
[TBL] [Abstract][Full Text] [Related]
10. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
11. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB
Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703
[TBL] [Abstract][Full Text] [Related]
12. Progesterone vaginal ring for contraceptive use during lactation.
Nath A; Sitruk-Ware R
Contraception; 2010 Nov; 82(5):428-34. PubMed ID: 20933116
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.
Weisberg E; Fraser IS; Mishell DR; Lacarra M; Darney P; Jackanicz TM
Contraception; 1999 May; 59(5):305-10. PubMed ID: 10494484
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
[TBL] [Abstract][Full Text] [Related]
16. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
17. Fertility regulation in nursing women. II. Comparative performance of progesterone implants versus placebo and copper T.
Croxatto HB; Díaz S; Peralta O; Juez G; Casado ME; Salvatierra AM; Durán E
Am J Obstet Gynecol; 1982 Sep; 144(2):201-8. PubMed ID: 7114130
[TBL] [Abstract][Full Text] [Related]
18. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
Hall P; Bahamondes L; Diaz J; Petta C
Contraception; 1997 Dec; 56(6):353-9. PubMed ID: 9494768
[TBL] [Abstract][Full Text] [Related]
19. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring.
Díaz S; Jackanicz TM; Herreros C; Juez G; Peralta O; Miranda P; Casado ME; Schiapacasse V; Salvatierra AM; Brandeis A
Contraception; 1985 Dec; 32(6):603-22. PubMed ID: 3912105
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
